The protective effect of curcumin on Aββ induced aberrant cell cycle reentry on primary cultured rat cortical neurons

European Review for Medical and Pharmacological Sciences

Volumn 16, Issue 4, 2012, Pages 445-454

  Wang, J ^a   Zhang, Y J ^a   Du, S ^a  

^a TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Alzheimer's disease; Cell cycle; Curcumin; Rat cortical neurons

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; AMYLOID BETA PROTEIN[25-35]; BROXURIDINE; CASPASE 3; CURCUMIN; CYCLIN D1; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN (25 35); AMYLOID BETA-PROTEIN (25-35); CASP3 PROTEIN, RAT; CCND1 PROTEIN, RAT; NEUROPROTECTIVE AGENT; PEPTIDE FRAGMENT;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BRAIN CELL; CELL CYCLE PARAMETERS; CELL CYCLE REGULATION; CONTROLLED STUDY; DOWN REGULATION; IN VITRO STUDY; NERVE CELL CULTURE; NEUROTOXICITY; NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; RAT; REVIEW; WESTERN BLOTTING; ANIMAL; ARTICLE; BRAIN CORTEX; CELL CULTURE; CELL CYCLE CHECKPOINT; CELL DEATH; CELL PROTECTION; CHEMISTRY; DOSE RESPONSE; DRUG EFFECT; METABOLISM; NERVE CELL; PATHOLOGY; PRENATAL DEVELOPMENT;

AMYLOID BETA-PEPTIDES; ANIMALS; BLOTTING, WESTERN; CASPASE 3; CELL CYCLE CHECKPOINTS; CELL DEATH; CELLS, CULTURED; CEREBRAL CORTEX; CURCUMIN; CYCLIN D1; CYTOPROTECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; IN SITU NICK-END LABELING; NEURONS; NEUROPROTECTIVE AGENTS; PEPTIDE FRAGMENTS; RATS;

EID: 84862666315     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. SMITH MA. Alzheimer disease. Int Rev Neurobiol 1998; 42:1-54.
2. EVANS DA, FUNKENSTEIN HH, ALBERT MS, SCHERR PA, COOK NR, CHOWN MJ, HEBERT LE, HENNEKENS CH, TAYLOR JO. Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. JAMA 1989; 262: 2551-2556.
3. LEE HG, CASADESUS G, ZHU X, CASTELLANI RJ, MCSHEA A, PERRY G, PETERSEN RB, BAJIC V, SMITH MA. Cell cycle re-entry mediated neurodegeneration and its treatment role in the pathogenesis of Alzheimer's disease. Neurochem Int 2009; 54: 84-88.
4. MCSHEA A, LEE HG, PETERSEN RB, CASADESUS G, VINCENT I, LINFORD NJ, FUNK JO, SHAPIRO RA, SMITH MA. Neuronal cell cycle re-entry mediates Alzheimer disease-type changes. Biochim Biophys Acta 2007; 1772: 467-472.
5. NAGY Z, ESIRI MM, CATO AM, SMITH AD. Cell cycle markers in the hippocampus in Alzheimer's disease. Acta Neuropathol 1997; 94: 6-15.
6. VINCENT I, JICHA G, ROSADO M, DICKSON DW. Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain. J Neurosci 1997; 17: 3588-3598.
7. SMITH MZ, NAGY Z, ESIRI MM. Cell cycle-related protein expression in vascular dementia and Alzheimer's disease. Neurosci Lett 1999; 271: 45-48.
8. BUSSER J, GELDMACHER DS, HERRUP K. Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's disease brain. J Neurosci 1998; 18: 2801-2807.
9. YANG Y, MUFSON EJ, AND HERRUP K. Neuronal cell death is preceded by cell cycle events at all stages of Alzheimer's disease. J Neurosci 2003; 23: 2557-2563.
10. ZHU X, SIEDLAK SL, WANG Y, PERRY G, CASTELLANI RJ, COHEN ML, SMITH MA. Neuronal binucleation in Alzheimer disease hippocampus. Neuropathology and Appl Neurobiol 2008; 34: 457-465.
11. MEHTA K, PANTAZIS P, MCQUEEN T, AGGARWAL BB. Antiproliferative effect of curcumin (diferuloylmethane) against human breast tumor cell lines. Anticancer Drug 1997; 8: 470-481.
12. JURENKA JS. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: A review of preclinical and clinical research. Altern Med Rev 2009; 14: 141-153.
13. MORIMOTO T, SUNAGAWA Y, FUJITA M, HASEGAWA K. Novel heart failure therapy targeting transcriptional pathway in cardiomyocytes by a natural compound, curcumin. Circ J 2010; 74: 1059-1066.
14. HATCHER H, PLANALP R, CHO J, TORTI FM, TORTI SV. Curcumin: From ancient medicine to current clinical trials. Cell Mol Life Sci 2008; 65: 1631-1652.
15. SAHA A, KUZUHARA T, ECHIGO N, FUJII A, SUGANUMA M, FUJIKI H. Apoptosis of human lung cancer cells by curcumin mediated through up-regulation of "growth arrest and DNA damage inducible genes 45 and 153". Biol Pharm Bull 2010; 33: 1291-1299.
16. RAVINDRAN J, PRASAD S, AGGARWAL BB. Curcumin and cancer cells: How many ways can curry kill tumor cells selectively? AAPS J 2009; 11: 495-510.
17. QIN XY, CHENG Y, CUI J, ZHANG Y, YU LC. Potential protection of curcumin against amyloid beta-induced toxicity on cultured rat prefrontal cortical neurons. Neurosci Lett 2009; 463: 158-161.
18. QIN XY, CHENG Y, YU LC. Potential protection of curcumin against intracellular amyloid beta-induced toxicity in cultured rat prefrontal cortical neurons. Neurosci Lett 2010; 480: 21-24.
19. BEGUM AN, JONES MR, LIM GP, MORIHARA T, KIM P, HEATH DD, ROCK CL, PRUITT MA, YANG F, HUDSPETH B, HU S, FAULL KF, TETER B, COLE GM, FRAUTSCHY SA. Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease. J Pharmacol Exp Ther 2008; 326: 196-208.
20. GARCIA-ALLOZA M, BORRELLI LA, ROZKALNE A, HYMAN BT, BACSKAI BJ. Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model. J Neurochem 2007; 102: 1095-1104.
21. YOON SY, CHOI JE, KWEON HS, CHOE H, KIM SW, HWANG O, LEE H, LEE JY, KIM DH. Okadaic acid increases autophagosomes in rat neurons: Implications for Alzheimer's disease. J Neurosci Res 2008; 86: 3230-3239.
22. WANG R, LI YH, XU Y, LI YB, WU HL, GUO H, ZHANG JZ, ZHANG JJ, PAN XY, LI XJ. Curcumin produces neuroprotective effects via activating brain-derived neurotrophic factor/TrkB-dependent MAPK and PI-3K cascades in rodent cortical neurons. Prog Neuropsychopharmacol Biol Psychiatry 2010; 34: 147-153.
23. HARDY J. Alzheimer's disease: The amyloid cascade hypothesis: An update and reappraisal. J Alzheimers Dis 2006; 9: 151-153.
24. MASTERS CL, BEYREUTHER K. Pathways to the discovery of the Abeta amyloid of Alzheimer's disease. J Alzheimers Dis 2006; 9: 155-161.
25. LOO DT, COPANI A, PIKE CJ, WHITTEMORE ER, WALENCEWICZ AJ, COTMAN CW. Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. Proc Natl Acad Sci 1993; 90: 7951-7955.
26. BATEMAN DA, CHAKRABARTTY A. Interactions of Alzheimer amyloid peptides with cultured cells and brain tissue, and their biological consequences. Biopolymers 2004; 76: 4-14.
27. YANKNER BA, DAWES LR, FISHER S, VILLA-KOMAROFF L, OSTER-GRANITE ML, NEVE RL. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science 1989; 245: 417-420.
28. CRAFT JM, WATTERSON DM, HIRSCH E, VAN ELDIK LJ. Interleukin 1 receptor antagonist knockout mice show enhanced microglial activation and neuronal damage induced by intracerebroventricular infusion of human beta-amyloid. J Neuroinflammation 2005; 2: 15.
29. MRUTHINTI S, CAPITO N, SOOD A, BUCCAFUSC JJ. Cytotoxicity of Abeta1-42, RAGE23-54, and an Abeta-RAGE complex in PC-12 cells. Curr Alzheimer Res 2007; 4: 581-586.
30. IRIE K, MURAKAMI K, MASUDA Y, MORIMOTO A, OHIGASHI H, HARA H, OHASHI R, TAKEGOSHI K, FUKUDA H, NAGAO M, SHIMIZU T, SHIRASAWA T. The toxic conformation of the 42-residue amyloid beta peptide and its relevance to oxidative stress in Alzheimer's disease. Mini Rev Med Chem 2007; 7: 1001-1108.
31. BAYDAS G, REITER RJ, AKBULUT M, TUZCU M, TAMER S. Melatonin inhibits neural apoptosis induced by homocysteine in hippocampus of rats via inhibition of cytochrome c translocation and caspase-3 activation and by regulating pro-and anti-apoptotic protein levels. Neuroscience 2005; 35: 879-886.
32. GERVAIS FG, XU D, ROBERTSON GS, VAILLANCOURT JP, ZHU Y, HUANG J, LEBLANC A, SMITH D, RIGBY M, SHEARMAN MS, CLARKE EE, ZHENG H, VAN DER PLOEG LH, RUFFOLO SC, THORNBERRY NA, XANTHOUDAKIS S, ZAMBONI RJ, ROY S, NICHOLSON DW. Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation. Cell 1999; 97: 395-406.
33. UETSUKI T, TAKEMOTO K, NISHIMURA I, OKAMOTO M, NIINOBE M, MOMOI T, MIURA M, YOSHIKAWA K. Activation of neuronal caspase-3 by intracellular accumulation of wild-type Alzheimer amyloid precursor protein. Neuroscience 1999; 19: 6955-6964.
34. CHEN XH, SIMAN R, IWATA A, MEANEY DF, TROJANOWSKI JQ, SMITH DH. Long-term accumulation of amyloid-beta, beta-secretase, presenilin-1, and caspase-3 in damaged axons following brain trauma. Am J Pathol 2004; 165: 357-371.
35. HUSSEMAN JW, NOCHLIN D, VINCENT I. Mitotic activation: A convergent mechanism for a cohort of neurodegenerative diseases. Neurobiol Aging 2000; 21: 815-828.
36. COPANI A, UBERTI D, SORTINO MA, BRUNO V, NICOLETTI F, MEMO M. Activation of cell-cycle-associated proteins in neuronal death: A mandatory or dispensable path? Trends Neurosci 2001; 24: 25-31.
37. BUSSER J, GELDMACHER DS, HERRUP K. Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's disease brain. Neuroscience 1998; 18: 2801-2807.
38. OGAWA O, ZHU X, LEE HG, RAINA A, OBRENOVICH ME, BOWSER R, GHANBARI HA, CASTELLANI RJ, PERRY G, SMITH MA. Ectopic localization of phosphorylated histone H3 in Alzheimer's disease: A mitotic catastrophe? Acta Neuropathol 2003; 105: 524-528.
39. YANG Y, GELDMACHER DS, HERRUP K. DNA replication precedes neuronal cell death in Alzheimer's disease. J Neurosci 2001; 21: 2661-2668.
40. ZHU X, RAINA AK, PERRY G, SMITH MA. Apoptosis in Alzheimer disease: A mathematical improbability. Curr Alzheimer Res 2006; 3: 393-396.
41. PERRY G, NUNOMURA A, LUCASSEN P, LASSMANN H, SMITH MA. Apoptosis and Alzheimer's disease. Science 1998; 282: 1268-1269.
42. MCDONALD DR, BAMBERGER ME, COMBS CK, LANDRETH GE. beta-Amyloid fibrils activate parallel mitogenactivated protein kinase pathways in microglia and THP1 monocytes. J Neurosci 1998; 18: 4451-4460.
43. PYO H, JOU I, JUNG S, HONG S, JOE EH. Mitogen-activated protein kinases activated by lipopolysaccharide and beta-amyloid in cultured rat microglia. Neuroreport 1998; 9: 871-874.
44. GIOVANNI A, WIRTZ-BRUGGER F, KERAMARIS E, SLACK R, PARK DS. Involvement of cell cycle elements, cyclin-dependent kinases, pRb, and E2F x DP, in Bamyloid-induced neuronal death. J Biol Chem 1999; 274: 19011-19016.
45. LEE HG, CASADESUS G, NUNOMURA A, ZHU X, CASTELLANI RJ, RICHARDSON SL, PERRY G, FELSHER DW, PETERSEN RB, SMITH MA. The neuronal expression of MYC causes a neurodegenerative phenotype in a novel transgenic mouse. Am J Pathol 2009; 174: 891-897.
46. BONDA DJ, EVANS TA, SANTOCANALE C, LLOSÁ JC, VINA J, BAJIC VP, CASTELLANI RJ, SIEDLAK SL, PERRY G, SMITH MA, LEE HG. Evidence for the progression through S-phase in the ectopic cell cycle re-entry of neurons in Alzheimer disease. Aging 2009; 1: 382-388.